⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
businesswire.com
REGN
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight
globenewswire.com
AZN
NVS
ABBV
BMY
GILD
REGN
VRTX
BIIB
JNJ
MRK
ARWR
TAK
VERA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
accessnewswire.com
REGN
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
globenewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
globenewswire.com
REGN
Quantified Launches New AI Sales Coaching Platform to Transform How Life Sciences Teams Prepare, Coach, and Win
prnewswire.com
JNJ
REGN
TSEM
SAN
UCB
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
accessnewswire.com
REGN
Retool Achieves AWS Consumer Goods Competency
businesswire.com
AMZN
COIN
DDOG
ADBE
NFLX
AAPL
GOOG
CHTR
NVDA
MSFT
INTC
AMD
TSLA
META
CRM
IBM
ORCL
CSCO
ACN
PYPL
UPST
PLTR
SNOW
CRWD
PANW
ZS
MDB
AFRM
SOFI
UPWK
FIVN
DOCU
SMCI
ASML
AMAT
KLAC
LRCX
MU
WDC
NXPI
QCOM
MRVL
ADSK
CDNS
SNPS
AMGN
GILD
BMY
LLY
REGN
VRTX
BIIB
AZN
XOM
CVX
SHEL
T
VZ
TMUS
CMCSA
DIS
GOOGL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
accessnewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
accessnewswire.com
REGN